FRM
CRL icon

Fox Run Management’s Charles River Laboratories CRL Stock Holding History

Fox Run Management’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$767K Buy
+2,600
New +$685K 0.09% 424
2025
Q3 		– Sell
-2,637
Closed -$400K – 979
2025
Q2 		$400K Buy
+2,637
New +$352K 0.07% 548
2023
Q2 		– Sell
-4,320
Closed -$872K – 743
2023
Q1 		$872K Buy
+4,320
New +$979K 0.28% 90
2022
Q3 		– Sell
-2,549
Closed -$545K – 641
2022
Q2 		$545K Buy
+2,549
New +$623K 0.27% 101
2020
Q3 		– Sell
-1,154
Closed -$201K – 198
2020
Q2 		$201K Buy
+1,154
New +$184K 0.27% 215
2019
Q1 		– Sell
-7,116
Closed -$805K – 502
2018
Q4 		$805K Buy
+7,116
New +$891K 0.43% 20
2018
Q2 		– Sell
-6,660
Closed -$711K – 707
2018
Q1 		$711K Buy
+6,660
New +$718K 0.17% 190
2017
Q4 		– Sell
-4,400
Closed -$475K – 702
2017
Q3 		$475K Buy
+4,400
New +$452K 0.13% 311
2017
Q2 		– Sell
-7,400
Closed -$666K – 664
2017
Q1 		$666K Sell
7,400
-2,700
-27% -$229K 0.27% 97
2016
Q4 		$770K Buy
10,100
+1,200
+13% +$91.1K 0.4% 26
2016
Q3 		$742K Sell
8,900
-300
-3% -$25.1K 0.44% 20
2016
Q2 		$758K Buy
+9,200
New +$758K 0.37% 30

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Ariel Investments
Ariel Investments Chicago, Illinois $9.6B AUM 22.21% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $25.4B AUM 35.48% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $296B AUM 23.14% 1-Year Est. Return

Fox Run Management's CRL Position: Q3 2026 in Review

Fox Run Management opened a new position in Charles River Laboratories (CRL) in Q3 2026: 2,600 shares worth $767K. The stake represents 0.09% of the portfolio and ranks #424 among its holdings. This is a return to the name: Fox Run Management previously reported a position in CRL as recently as Q2 2025.

Fox Run Management first reported a position in CRL in Q2 2016 and has held it in 12 quarters since. The position peaked at $872K in Q1 2023. 515 funds tracked by Wall St. Rank hold CRL as of Q3 2026.

  • Fox Run Management held 2,600 shares of Charles River Laboratories worth $767K as of Q3 2026.
  • Charles River Laboratories was a new Fox Run Management position in Q3 2026.
  • Charles River Laboratories made up 0.09% of Fox Run Management's portfolio in Q3 2026, its #424 holding.
  • Fox Run Management first reported a position in Charles River Laboratories in Q2 2016 and has held it in 12 quarters since.
  • Fox Run Management's Charles River Laboratories position peaked at $872K in Q1 2023.
  • 515 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2026.

Based on Fox Run Management's 13F filing for Q3 2026, filed 12 Nov 2026.